Susan Elizabeth Arnold serves as Executive at PhaseBio Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Susan Elizabeth Arnold has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 20, 2022 involved receiving (via award) 10,917 shares valued at $7.4K.
Susan Elizabeth Arnold currently holds 41,236 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Elizabeth Arnold has been a net neutral trader of PHAS stock. They have purchased $0 and sold $0 worth of shares.
Susan Elizabeth Arnold's most recent insider trade was on May 20, 2022, when they sold 10,917 shares at $0.68 per share.
Get notified when new Form 4 filings are submitted
| $2.01 |
| Discretionary |
| Jul 12, 2021 | PHAS | $7.9K | Award | 4,519 | $1.74 | Discretionary |
| Jul 12, 2021 | PHAS | $7.9K | Option Exercise | 4,519 | $1.74 | Discretionary |
| May 20, 2021 | PHAS | $14.7K | Award | 5,257 | $2.80 | Discretionary |
| Nov 20, 2020 | PHAS | $14.5K | Award | 4,832 | $3.00 | Discretionary |
| Oct 1, 2020 | PHAS | $6.2K | Option Exercise | 5,423 | $1.15 | Discretionary |
| Feb 27, 2020 | PHAS | $6.2K | Option Exercise | 5,423 | $1.15 | Discretionary |
| Oct 22, 2018 | PHAS | $0 | Conversion | 2,306 | $N/A | Discretionary |